Form 4: Anterix Executive Chairman Thomas Kuhn Receives Equity Grant
Insider Transaction Report
Anterix Inc. Executive Chairman Thomas R. Kuhn was granted 6,222 restricted stock units, increasing his total beneficial ownership to 16,594 shares.
Summary
- Thomas R. Kuhn, Executive Chairman and Director of Anterix Inc. (ATEX), acquired 6,222 shares of Common Stock.
- The transaction occurred on June 12, 2025, at a price of $0 per share, indicating a grant of restricted stock units (RSUs).
- Following this acquisition, Mr. Kuhn's total beneficial ownership of Anterix Common Stock increased to 16,594 shares.
- Each RSU represents a contingent right to receive one share of Common Stock and vests in full on the earlier of June 12, 2026, or the Issuer's next annual stockholder meeting.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive as it indicates an increase in insider ownership and alignment of executive interests with shareholders, although it's a routine compensation grant rather than an open market purchase.
Positives
- The grant of restricted stock units to Executive Chairman Thomas R. Kuhn aligns management's interests with those of shareholders, as the value of the grant is tied to the company's stock performance.
- An increase in beneficial ownership by a key executive can signal confidence in the company's future prospects.
Negatives
- No explicit negatives are detailed in this Form 4 filing.
Risks
- The value of the granted restricted stock units is subject to the future performance of Anterix Inc.'s common stock.
- The vesting of the RSUs is contingent upon specific dates or events (June 12, 2026, or the next annual stockholder meeting), meaning the shares are not immediately available to the executive.
Future Outlook
The restricted stock units granted to Executive Chairman Thomas R. Kuhn are set to vest in full on the earlier of June 12, 2026, or the Issuer's next annual stockholder meeting, indicating a future milestone for the executive's equity compensation.
Industry Context
This Form 4 filing is a routine disclosure of executive equity compensation, a common practice across industries to align management incentives with shareholder value. It does not provide broader industry trends or competitive analysis.
Related Party Transactions
- The transaction involves the grant of restricted stock units to Thomas R. Kuhn, an executive and director of Anterix Inc., which is a form of compensation from the company to a related party.
Stakeholder Impact
- Shareholders: Increased alignment of executive interests with shareholder value due to equity-based compensation.
- Employees: No direct impact on general employees mentioned.
- Customers/Suppliers/Creditors: No direct impact mentioned.
Next Steps
- The restricted stock units are scheduled to vest on the earlier of June 12, 2026, or the Issuer's next annual stockholder meeting.
Key Dates
| Date | Description |
|---|---|
| 06/12/2025 | Date of transaction where Thomas R. Kuhn acquired 6,222 restricted stock units. |
| 06/16/2025 | Date the Form 4 was signed by Gena L. Ashe, Attorney-in-Fact for Thomas R. Kuhn. |
| 06/12/2026 | Latest vesting date for the restricted stock units, or earlier upon the Issuer's next annual stockholder meeting. |
Keywords
Anterix Inc., ATEX, Form 4, SEC filing, insider transaction, restricted stock units, RSU, equity grant, Thomas R. Kuhn, executive compensation, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.